SCHEMBL8048188

SCHEMBL8048188

C[C@@]12CCC[C@H]1[C@@H]1CCc3ccccc3[C@@]1(O)CC2

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.40
MAPK1 P28482 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SRD5A1 P18405 1/20 0.36
KDM1A O60341 1/20 0.36
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8038167 1.00 SHBG (0.40) SHBGMAPK1SMN1; SMN2SRD5A1KDM1A
SCHEMBL8048190 1.00 SHBG (0.40) SHBGMAPK1SMN1; SMN2SRD5A1KDM1A
SCHEMBL8052596 0.78 SHBG (0.36) SHBGSRD5A1KDM1A
SCHEMBL8052597 0.78 SHBG (0.36) SHBGSRD5A1KDM1A
SCHEMBL8038117 0.77 ESR1 (0.50) SHBGMAPK1SMN1; SMN2
SCHEMBL8050411 0.77 ESR1 (0.50) SHBGSRD5A1
SCHEMBL7213772 0.71 SHBG (0.44) SHBGCHRM2CHRM1CHRM3
SCHEMBL7516092 0.70 CHRM2 (0.34) MAPK1SMN1; SMN2SRD5A1KDM1ACHRM2
SCHEMBL7508416 0.69 ESR1 (0.34) MAPK1SMN1; SMN2SRD5A1CHRM2CHRM4
SCHEMBL1427141 0.68 MAPK1 (0.50) MAPK1SMN1; SMN2KDM1ACHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882735-B1 9 Alpha-hydroxy-8 alpha-estra-1,3,5(10)-trienes and a process for their preparation JENAPHARM GMBH (DE) 2000-04-19 EP disclosed
EP-0882735-A1 9 Alpha-hydroxy-8 alpha-estra-1,3,5(10)-trienes and a process for their preparation Jenapharm GmbH & Co. KG (DE) 1998-12-09 EP disclosed